Get Fletcher Spaght Ventures contact and information in the United States

Investor Type	Firm
Type of Fund	Venture Capital Fund
Industries	Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Retail (& E-Commerce) • Consumer
Stages	Seed, Series A, Series B
Investing	United States
Investment Range	$2,378,923 - $40,000,000

Who are the key investors at Fletcher Spaght Ventures?

What is Fletcher Spaght Ventures?

Fletcher Spaght Ventures is a venture capital firm that operates out of Boston, Massachusetts, and reflects a deep-seated expertise in fostering the growth of emerging companies. Established in 2001 as an arm of Fletcher Spaght, Inc. (FSI), a strategy consulting firm founded in 1983, they have carved out a niche in transforming innovative ventures into market leaders.

The firm pivots on key sectors such as healthcare, life sciences, information technology, software (including Web Marketplace Saas), BioTech, and Retail (& E-Commerce). Fletcher Spaght Ventures brings to the table an extensive investment range, with a minimum of $2,378,923 and capping out at $40,000,000, allowing them to provide significant resources for business expansion and scale.

Their dual proficiency in strategy consulting and venture capital offers a unique perspective on company growth, driving actionable growth plans grounded in rigorous analytical methodologies. FSI's verticals include Diagnostics & Life Science Tools, Medtech, Digital Health & HCIT, Healthcare Services, and Biopharma & CRO, signifying a comprehensive approach to engaging with businesses at various intersections of technology and service delivery. Additionally, they offer deep expertise in transactions and due diligence, further substantiating their position as growth-focused consultants.

FSI's commitment to direct participation by senior staff ensures that their portfolio companies benefit from decades of firsthand operational experience, a key differentiator that has established their reputation for propelling companies forward. With a team of highly qualified professionals from specialized backgrounds in healthcare, finance, and technology, Fletcher Spaght Ventures embeds itself as an integral component in the trajectory of businesses ready to ascend to the next level of their corporate evolutions.

What they say:

We provide strategic and financial assistance to these ventures.

What we look for: We invest in new ventures, including startups, within consumer, information technology, medical, and medical device sectors.

Fletcher Spaght Ventures's investments on record

PhaseBio Pharmaceuticals	$40,000,000.00	Series C
PhaseBio	$34,000,000.00
Cheetah Medical	$28,849,535.00	Series C
Metabolon	$14,999,980.00	Series E
Cheetah Medical	$11,760,000.00	Series C
HistoSonics	$8,260,313.00	Series B
PhaseBio Pharmaceuticals	$8,100,000.00	Convertible Note
SurgiQuest	$7,500,000.00	Series D
Swift Biosciences	$7,000,000.00	Series B